Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
18-Aug-25 | Sell | Dame Kay Davies | 500.40p | 4,563 | £22,833.25 |
15-Aug-25 | Buy | Roch Doliveux | 449.75p | 67,000 | £301,332.50 |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
15-Aug-25 | Buy | Roch Doliveux | 449.75p | 67,000 | £301,332.50 |
18-Aug-25 | Sell | Dame Kay Davies | 500.40p | 4,563 | £22,833.25 |
Notifier | Holding | Value* |
---|---|---|
Roch Doliveux | 376,808 | £2,234,471 |
Heather Preston | 29,687 | £176,044 |
Frank Mathias | 20,000 | £118,600 |
Namrata P Patel | 9,170 | £54,378 |
Dame Kay Davies | 1,000 | £5,930 |
Notifier** | Holding | Value* |
---|---|---|
Briarwood Chase Management LLC | 18,638,801 | £110,528,090 |
Briarwood Chase Management LLC | 13,851,927 | £82,141,927 |
Novo Nordisk Foundation | 12,048,802 | £71,449,396 |
Institut Merieux SA | 11,510,481 | £68,257,152 |
VULPES LIFE SCIENCES FUND | 8,447,390 | £50,093,023 |
Liontrust Asset Management | 6,078,799 | £36,047,278 |
M&G Plc | 5,872,847 | £34,825,983 |
Legal & General Group Plc | 5,760,126 | £34,157,547 |
HSBC Global Custody Nominee (UK) Ltd | 4,700,000 | £27,871,000 |
Ameriprise Financial, Inc. | 4,108,146 | £24,361,306 |
Columbia Threadneedle Investments (London) | 3,834,977 | £22,741,414 |
Canaccord Genuity Group Inc | 3,699,438 | £21,937,667 |
Hargreaves Lansdown Asset Management | 3,475,237 | £20,608,155 |
SERUM LIFE SCIENCES LTD | 3,382,950 | £20,060,894 |
Nine Ten Capital | 3,117,228 | £18,485,162 |
Lansdowne Partners (London) | 3,085,765 | £18,298,586 |
Mr. S Shah | 2,898,750 | £17,189,588 |
Artisan Partners | 2,620,800 | £15,541,344 |
Cubana Investments Limited | 2,506,000 | £14,860,580 |
Interactive Investor Sharedealing | 2,372,412 | £14,068,403 |
TDWaterhouse | 852,076 | £5,052,811 |
Self Trade Stockbrokers | 657,039 | £3,896,241 |
Currency | UK Pounds |
Share Price | 593.00p |
Change Today | 3.00p |
% Change | 0.51 % |
52 Week High | 597.00p |
52 Week Low | 232.50p |
Volume | 219,461 |
Shares Issued | 120.18m |
Market Cap | £712.68m |
Beta | 0.01 |
RiskGrade | 125 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 4 |
Buy | 2 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 10 |
No dividends found |
Time | Volume / Share Price |
16:47 | 1,815 @ 591.44p |
16:35 | 534 @ 593.00p |
16:35 | 211 @ 593.00p |
16:35 | 532 @ 593.00p |
16:35 | 1,680 @ 593.00p |
Chair | Roch Doliveux |
CEO | Frank Mathias |
CFO | Lucinda (Lucy) Crabtree |
You are here: research